Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Technical Analysis

7,949 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting Crispr Therapeutics AG is a Sell.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 56.85, while Crispr Therapeutics AG’s (CRSP) share price is $58.04, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 57.62, while Crispr Therapeutics AG’s (CRSP) share price is $58.04, making it a Sell.

Crispr Therapeutics AG (CRSP) Pivot Points

Jul 26, 2024, 09:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
52.76
54.01
54.70
55.95
56.64
57.89
58.58
Fibonacci
54.01
54.75
55.21
55.95
56.69
57.15
57.89
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Jul 26, 2024, 09:09 PM
Period
Simple
Exponential
MA5
56.19Buy
56.79Buy
MA10
57.58Sell
56.82Buy
MA20
55.99Buy
56.85Buy
MA50
57.13Buy
57.62Sell
MA100
60.71Sell
59.17Sell
MA200
61.39Sell
58.53Sell
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 56.82, while Crispr Therapeutics AG’s (CRSP) share price is $58.04, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 59.17, while Crispr Therapeutics AG’s (CRSP) share price is $58.04, making it a Sell.
Crispr Therapeutics AG’s (CRSP) stock price is $58.04 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 57.13, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $58.04 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 60.71, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) stock price is $58.04 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 61.39, creating a Sell signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Jul 26, 2024, 09:09 PM
Name
Value
Implied Action
RSI (14)
51.47
Neutral
STOCH (9,6)
27.99
Neutral
STOCHRSI (14)
37.90
Neutral
MACD (12,26)
-0.10
Sell
ADX (14)
15.43
Buy
Williams %R
-56.31
Buy
CCI (14)
37.67
Neutral
ATR (14)
2.85
-
Ultimate Oscillator
37.89
Neutral
ROC
8.42
Buy
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 51.47, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 15.43, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is 37.67, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is 8.42, creating a Buy signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Buy.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 51.47, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is -0.10, which suggests CRSP is a Sell.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 56.19, which suggests CRSP is a Buy.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 55.99, which suggests CRSP is a Buy.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 57.13, which suggests CRSP is a Buy.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 61.39, which suggests CRSP is a Sell.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -56.31, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is 37.67, which suggests CRSP is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis